These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3160110)

  • 1. Inhibition of interferon-gamma may suppress allograft reactivity by T lymphocytes in vitro and in vivo.
    Landolfo S; Cofano F; Giovarelli M; Prat M; Cavallo G; Forni G
    Science; 1985 Jul; 229(4709):176-9. PubMed ID: 3160110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-gamma plays a crucial role in T lymphocyte reaction against alloantigens.
    Landolfo S; Cofano F; Giovarelli M; Prat M; Cavallo G; Forni G
    Ric Clin Lab; 1985; 15(4):307-14. PubMed ID: 2939532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of antiskin allograft immunity induced by infusions with photoinactivated effector T lymphocytes (PET cells). Is in vivo cell transferrable?
    Perez M; Lobo FM; Yamane Y; John L; Berger CL; Edelson RL
    Ann N Y Acad Sci; 1991 Dec; 636():95-112. PubMed ID: 1793234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of in vivo exposure to allogeneic cells upon subsequent in vitro T cell responses and upon allograft rejection.
    Cooley MA
    Scand J Immunol; 1978; 7(5):371-80. PubMed ID: 149361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies against murine IFN-gamma abrogate in vivo tumor immunity against RSV-induced murine sarcomas.
    Prat M; Bretti S; Amedeo M; Landolfo S; Comoglio PM
    J Immunol; 1987 Jun; 138(12):4530-3. PubMed ID: 3035023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Devising murine models to better adapt clinical protocols: sequential low-dose treatment with anti-CD3 and anti-CD4 monoclonal antibodies to prevent fully mismatched allograft rejection.
    Campos HH; Bach JF; Chatenoud L
    Transplant Proc; 1993 Feb; 25(1 Pt 1):798-9. PubMed ID: 8438486
    [No Abstract]   [Full Text] [Related]  

  • 7. Suppression of cytotoxic lymphocyte responses in vitro by soluble products of alloantigen-activated spleen cells.
    Truitt GA; Rich RR; Rich SS
    J Immunol; 1978 Sep; 121(3):1045-51. PubMed ID: 151115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of adenosine 2A receptors attenuates allograft rejection and alloantigen recognition.
    Sevigny CP; Li L; Awad AS; Huang L; McDuffie M; Linden J; Lobo PI; Okusa MD
    J Immunol; 2007 Apr; 178(7):4240-9. PubMed ID: 17371980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IFN-gamma- and cell-to-cell contact-dependent cytotoxicity of allograft-induced macrophages against syngeneic tumor cells and cell lines: an application of allografting to cancer treatment.
    Yoshida R; Yoneda Y; Kuriyama M; Kubota T
    J Immunol; 1999 Jul; 163(1):148-54. PubMed ID: 10384111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of IFN-gamma production by intravenous immunoglobulins during mixed lymphocyte reaction: consequences for proliferation and TNF-gamma production.
    Toungouz M; Denys C; Dupont E
    Transplant Proc; 1997; 29(1-2):1089. PubMed ID: 9123213
    [No Abstract]   [Full Text] [Related]  

  • 11. Early T cell response to allografts occurring prior to alloantigen priming up-regulates innate-mediated inflammation and graft necrosis.
    El-Sawy T; Miura M; Fairchild R
    Am J Pathol; 2004 Jul; 165(1):147-57. PubMed ID: 15215170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of in vitro cytotoxic T lymphocyte generation. II. Demonstration of noncytotoxic alloantigen-specific suppressor T lymphocytes.
    Schwartz A; Sutton SL; Gershon RK
    Eur J Immunol; 1982 May; 12(5):380-6. PubMed ID: 6212258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alloantigen-activated lymphocytes from mice bearing a spontaneous "nonimmunogenic" adenocarcinoma inhibit its growth in vivo by recruiting host immunoreactivity.
    Giovarelli M; Santoni A; Forni G
    J Immunol; 1985 Nov; 135(5):3596-603. PubMed ID: 3930610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic effects of Isatis tinctoria L. and tacrolimus in the prevention of acute heart rejection in mice.
    Wang Y; Qin Q; Chen J; Kuang X; Xia J; Xie B; Wang F; Liang H; Qi Z
    Transpl Immunol; 2009 Dec; 22(1-2):5-11. PubMed ID: 19766187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The development of primed/memory CD8+ lymphocytes in vitro and in rejecting kidneys after transplantation.
    Akbar AN; Amlot PL; Timms A; Lombardi G; Lechler R; Janossy G
    Clin Exp Immunol; 1990 Aug; 81(2):225-31. PubMed ID: 1974831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of heat-stable antigen on tumor cells provides co-stimulation for tumor-specific T cell proliferation and cytotoxicity in mice.
    Wang YC; Zhu L; McHugh R; Sell KW; Selvaraj P
    Eur J Immunol; 1995 May; 25(5):1163-7. PubMed ID: 7774619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isatis tinctoria L. combined with co-stimulatory molecules blockade prolongs survival of cardiac allografts in alloantigen-primed mice.
    Kang X; Chen J; Qin Q; Wang F; Wang Y; Lan T; Xu S; Wang F; Xia J; Ekberg H; Qi Z; Liu Z
    Transpl Immunol; 2010 May; 23(1-2):34-9. PubMed ID: 20338239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of transplantation immunity in vivo by monoclonal antibodies recognizing host class II restriction elements. II. Effects of anti-Ia immunotherapy on host T cell responses to graft alloantigens.
    Williams IR; Perry LL
    J Immunol; 1985 May; 134(5):2942-7. PubMed ID: 3156920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alloantigen-induced human lymphocytes rendered nonresponsive by a combination of anti-CD80 monoclonal antibodies and cyclosporin-A suppress mixed lymphocyte reaction in vitro.
    Comoli P; Montagna D; Moretta A; Zecca M; Locatelli F; Maccario R
    J Immunol; 1995 Dec; 155(12):5506-11. PubMed ID: 7499831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-LFA-1 therapy induces long-term islet allograft acceptance in the absence of IFN-gamma or IL-4.
    Nicolls MR; Coulombe M; Yang H; Bolwerk A; Gill RG
    J Immunol; 2000 Apr; 164(7):3627-34. PubMed ID: 10725719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.